Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Multiple insider buying at PharmaCielo (PCLO)

INK Research - Sat Mar 21, 5:10AM CDT
Company Chart of PCLO

Marc Lustig, a Director, acquired 453,429 Common Shares on a direct ownership basis at a price of $0.080 through a private transaction on March 16th, 2026. The insider also acquired 2,529,653 Common Shares on an indirect ownership basis for registered holder L5 Capital Inc. at a price of $0.080 through a private transaction on March 16th, 2026. This represents a $238,647 investment into the company's shares and an account share holdings change of 83.8%.

Let the insiders guide you to opportunity at Canadianinsider.com.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.